A review of health utilities using the EQ-5D in studies of cardiovascular disease

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Dyer, Matthew T D ^a,d   Goldsmith, Kimberley A ^b,c   Sharples, Linda S ^b,c   Buxton, Martin J ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ROYAL COLLEGE OF PSYCHIATRISTS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE SEVERITY; ECONOMIC EVALUATION; HEALTH CARE UTILIZATION; HEART FAILURE; HUMAN; MEDICAL DECISION MAKING; MEDICAL LITERATURE; OUTCOME ASSESSMENT; QUALITY ADJUSTED LIFE YEAR; RELIABILITY; RESOURCE ALLOCATION; VALIDITY; VISUAL ANALOG SCALE; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; REVIEW;

CARDIOVASCULAR DISEASES; HUMANS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 77349099303     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-13     Document Type: Article

References (95)

1. World Health Organisation The World Health Report 2003: Shaping the Future. Geneva 2003, World Health Organisation.
2. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006, 27:1610-1619. 10.1093/eurheartj/ehi733, 16495286.
3. Swenson JR, Clinch JJ. Assessment of quality of life in patients with cardiac disease - the role of psychosomatic medicine. J Psychosom Res 2000, 48:405-415. 10.1016/S0022-3999(99)00092-6, 10880662.
4. The Criteria Committee of the New York Heart Association Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels 1994, Boston, Mass.: Little, Brown & Co, 9, The Criteria Committee of the New York Heart Association.
5. Campeau L. The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later. Can J Cardiol 2002, 18:439-442.
6. Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonell M, Fihn SD. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995, 25:333-341. 10.1016/0735-1097(94)00397-9, 7829785.
7. Hofer S, Lim L, Guyatt G, Oldridge N. The MacNew Heart Disease health-related quality of life instrument: A summary. Health Qual Life Outcomes 2004, 2:3. 10.1186/1477-7525-2-3, 341459, 14713315.
8. Guyatt G. Measurement of health related quality of life in heart failure. J Am Coll Cardiol 1993, 22(Suppl A):185A-191A.
9. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002, 21:271-292. 10.1016/S0167-6296(01)00130-8, 11939242.
10. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med 2001, 33:375-384. 10.3109/07853890109002092, 11491197.
11. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33:337-343. 10.3109/07853890109002087, 11491192.
12. Dolan PD. Modelling Valuations for EuroQol Health States. Med Care 1997, 35(11):1095-1108. 10.1097/00005650-199711000-00002, 9366889.
13. Dankova I, Dlouhy M. The measurement of health status with Czech version of European quality of life questionnaire: version EQ-5D. Czech Health Policy Econ 2001, 2.
14. Wittrup-Jensen K, Lauridsen J, Gudex C, Brooks R, Pedersen K. Estimating Danish EQ-5D tariffs using the time trade-off (TTO) and visual analogue scale (VAS) methods. 257-292. Lund: Swedish Institute for Health Economics.
15. Lamers L, Stalmeier P, Krabbe P, Busschbach J. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 2006, 15:1121-1132. 10.1002/hec.1124, 16786549.
16. Claes C, Greiner W, Uber A, Schulenberg J-M. The new German version of the EuroQol quality of life questionnaire. 1-23. Centre for Health Policy and Law, Erasmus University Rotterdam.
17. Shaw JWP, Johnson JAP, Coons SJP. US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model. Med Care 2005, 43:203-220. 10.1097/00005650-200503000-00003, 15725977.
18. Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Krabbe P, Ohinmaa A, Parkin D, Roset M, Sintonen H, Tsuchiya A, Charro F. A single European currency for EQ-5D health states. Eur J Health Econ 2003, 4:222-231. 10.1007/s10198-003-0182-5, 15609189.
19. WHO International Statistical Classification of Diseases and Related Health Problems. Geneva 2007, WHO.
20. Higgins J, Thompson SG. Quantifying heterogeneity in meta-analysis. Stat Med 2002, 21:1539-1558. 10.1002/sim.1186, 12111919.
21. Schweikert B, Hahmann H, Leidl R. Validation of the EuroQol questionnaire in cardiac rehabilitation. Heart 2006, 92:62-67. 10.1136/hrt.2004.052787, 1860985, 15797936.
22. Nowels D, McGloin J, Westfall JM, Holcomb S. Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. Qual Life Res 2005, 14:95-105. 10.1007/s11136-004-0614-4, 15789944.
23. Pickard AS, Johnson JA, Feeny DH. Responsiveness of generic health-related quality of life measures in stroke. Qual Life Res 2005, 14:207-219. 10.1007/s11136-004-3928-3, 15789955.
24. Spertus J, Peterson E, Conard M, Heidenreich P, Rumholz M, Jones P, McCullogh PA, Pina I, Wooley J, Weintraub WS, Rumsfeld JS. Monitoring clinical changes in patients with heart failure: A comparison of methods. Am Heart J 2005, 150:707-715. 10.1016/j.ahj.2004.12.010, 16209970.
25. van Stel H, Buskens E. Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health Qual Life Outcomes 2006, 4:20. 10.1186/1477-7525-4-20, 1475841, 16563170.
26. Eurich D, Johnson J, Reid K, Spertus J. Assessing responsiveness of generic and specific health related quality of life measures in heart failure. Health Qual Life Outcomes 2006, 4:89. 10.1186/1477-7525-4-89, 1675990, 17125512.
27. Dorman P, Slattery J, Farrell B, Dennis M, Sandercock P. Qualitative Comparison of the Reliability of Health Status Assessments With the EuroQol and SF-36 Questionnaires After Stroke. Stroke 1998, 29:63-68.
28. Tangelder MJD, McDonnel J, Van Busschbach JJ, Buskens E, Algra A, Lawson JA, Eikelboom BC. Quality of life after infrainguinal bypass grafting surgery. Journal of Vascular Surgery 1999, 29:913-919. 10.1016/S0741-5214(99)70219-3, 10233784.
29. Pickard AS, Johnson JA, Feeny DH, Shuaib A, Carriere KC, Nasser AM. Agreement Between Patient and Proxy Assessments of Health-Related Quality of Life After Stroke Using the EQ-5D and Health Utilities Index. Stroke 2004, 35:607-612. 10.1161/01.STR.0000110984.91157.BD, 14726549.
30. Hage C, Mattsson E, Stahle A. Long term effects of exercise training on physical activity level and quality of life in elderly coronary patients - A three- to six-year follow-up. Physiother Res Int 2003, 8:13-22. 10.1002/pri.268, 12701462.
31. Haacke C, Althaus A, Spottke A, Siebert U, Back T, Dodel R. Long-Term Outcome After Stroke: Evaluating Health-Related Quality of Life Using Utility Measurements. Stroke 2006, 37:193-198. 10.1161/01.STR.0000196990.69412.fb, 16339458.
32. Schaaf IC, Wermer MJH, Velthuis BK, Buskens E, Bossuyt PMM, Rinkel GJE. Psychosocial impact of finding small aneurysms that are left untreated in patients previously operated on for ruptured aneurysms. J Neurol Neurosurg Psychiatry 2006, 77:748-752. 10.1136/jnnp.2005.079194, 2077475, 16705198.
33. Longworth L, Buxton M, Sculpher M, Smith D. Estimating utility data from clinical indicators for patients with stable angina. Eur J Health Econ 2005, 6:347-353. 10.1007/s10198-005-0309-y, 16193322.
34. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
35. Borowiak E, Kostka T. Influence of chronic cardiovascular disease and hospitalisation due to this disease on quality of life of community-dwelling elderly. Qual Life Res 2006, 15:1281-1289. 10.1007/s11136-006-0058-0, 16977423.
36. Lenzen M, Scholte op Reimer W, Norkvel TM, De Geest S, Fridlund B, Heikkila J, Jaarsma T, Mortensson J, Moons P, Smith K, Stewart S, Stromberg A, Thompson DR, Wijns W. Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization: Results from the Euro Heart Survey on Coronary Revascularization. Eur J Cardiovasc Nurs 2006, 5:115-121. 10.1016/j.ejcnurse.2006.01.003, 16530486.
37. Sollano JA, Rose EA, Williams DL, Thornton BM, Quint ER, Apfelbaum MM, Wasserman HM, Cannavale GA, Smith CR, Reemstma KM, Greene RJ. Cost-Effectiveness of Coronary Artery Bypass Surgery in Octogenarians. Annals of Surgery September 1998, 228(3):297-306.
38. Almenar-Pertejo M, Almenar L, Martinez-Dolz L, Campos J, Galan J, Girones P, Ortega F, Ortega T, Rebollo P, Salvador A. Study on Health-Related Quality of Life in Patients With Advanced Heart Failure Before and After Transplantation. Transplant Proc 2006, 38:2524-2526. 10.1016/j.transproceed.2006.08.017, 17097988.
39. Austin J, Williams WR, Ross L, Hutchison S. Five-year follow-up findings from a randomized controlled trial of cardiac rehabilitation for heart failure. Eur J Cardiovasc Prev Rehabil 2008, 15:162-167. 10.1097/HJR.0b013e3282f10e87, 18391642.
40. Calvert MJ, Freemantle N, Cleland JGF. The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur J Heart Fail 2005, 7:243-251. 10.1016/j.ejheart.2005.01.012, 15701474.
41. Hofer S, Kullich W, Graninger U, Brandt D, Gassner A, Klicpera M, Laimer H, Marko C, Schwann H, Moller R. Cardiac rehabilitation in Austria: short term quality of life improvements in patients with heart disease. Wien Klin Wochenschr 2006, 118:744-753. 10.1007/s00508-006-0727-6, 17186170.
42. Lottman PEM, Laheij RJF, Cuypers PWM, Bender M, Buth J. Health-related quality of life outcomes following elective open or endovascular AAA Repair: A randomised controlled trial. J Endovasc Surg 2004, 11:323-329.
43. Sulch D, Melbourn A, Perez I, Kalra L. Integrated Care Pathways and Quality of Life on a Stroke Rehabilitation Unit. Stroke 2002, 33:1600-1604. 10.1161/01.STR.0000017144.04043.87, 12052998.
44. Bosch J, Hunink M. Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication. Qual Life Res 2000, 9:591-601. 10.1023/A:1008929129537, 11236850.
45. Jowett S, Bryan S, Murray E, McCahon D, Raftery J, Hobbs F, Fitzmaurice D. Patient self-management of anticoagulation therapy: a trial-based cost-effectiveness analysis. Br J Haematol 2006, 134:632-639. 10.1111/j.1365-2141.2006.06243.x, 16938120.
46. Granja C, Cabral G, Pinto A, Costa-Pereira A. Quality of life 6-months after cardiac arrest. Resuscitation 2002, 55:37-44. 10.1016/S0300-9572(02)00203-4, 12297352.
47. Pickard AS, Wilke CT, Lin HW, Lloyd A. Health Utilities Using the EQ-5D in Studies of Cancer. Pharmacoeconomics 2007, 25:365-384. 10.2165/00019053-200725050-00002, 17488136.
48. Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med 2008, 102:519-536. 10.1016/j.rmed.2007.11.016, 18180151.
49. Sullivan PW, Lawrence WF, Ghushchyan VM. A National Catalog of Preference-Based Scores for Chronic Conditions in the United States. Med Care 2005, 43:736-749. 10.1097/01.mlr.0000172050.67085.4f, 15970790.
50. Tengs TO, Wallace AM. One Thousand Health-Related Quality-of-Life Estimates. Med Care 2000, 38:583-637. 10.1097/00005650-200006000-00004, 10843310.
51. Higgins J, Thompson S, Deeks J, Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 2002, 7:51-61. 10.1258/1355819021927674, 11822262.
52. Shrive FM, Ghali WA, Johnson JA, Donaldson CP, Manns BJ. Use of the U.S. and U.K. Scoring Algorithm for the EuroQol-5D in an Economic Evaluation of Cardiac Care. Med Care 2007, 45:269-273. 10.1097/01.mlr.0000250480.55578.45, 17304086.
53. Ascione R, Reeves BC, Taylor FC, Seehra HK, Angelini GD. Beating heart against cardioplegic arrest studies (BHACAS 1 and 2): quality of life at mid-term follow-up in two randomised controlled trials. Eur Heart J 2004, 25:765-770. 10.1016/j.ehj.2003.11.015, 15120887.
54. Rocca HPB-L, Kaiser C, Bernheim A, Zellweger MJ, Jeger R, Buser PT, Osswald S, Pfisterer M. Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitats Trial (BASKET): an 18-month analysis. Lancet 2007, 370:1552-1559. 10.1016/S0140-6736(07)61660-2, 17980734.
55. Denvir MA, Lee AJ, Rysdale J, Walker A, Eteiba H, Starkey IR, Pell JP. Influence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary intervention. J Epidemiol Community Health 2006, 60:1085-1088. 10.1136/jech.2005.044255, 2465496, 17108307.
56. Dunning J, Waller JRL, Smith B, Pitts S, Kendall SWH, Khan K. Coronary Artery Bypass Grafting is Associated With Excellent Long-Term Survival and Quality of Life: A Prospective Cohort Study. Ann Thorac Surg 2008, 85:1988-1993. 10.1016/j.athoracsur.2008.02.024, 18498808.
57. Eefting F, Nathoe H, van Dijk D, Jansen E, Lahpor J, Stella P, Suyker W, Diephuis J, Suryapranda H, Ernst S, Borst C, Buskens E, Grobbee D, de Jaegere P. Randomized Comparison Between Stenting and Off-Pump Bypass Surgery in Patients Referred for Angioplasty. Circulation 2003, 108:2870-2876. 10.1161/01.CIR.0000100723.50363.2C, 14656913.
58. Griffin SC, Barber JA, Manca A, Sculpher MJ, Thompson SG, Buxton MJ, Hemingway H. Cost effectiveness of clinically appropriate decisions on alternative treatments for angina pectoris: prospective observational study. BMJ 2007, 334:624-628. 10.1136/bmj.39129.442164.55, 1832000, 17339236.
59. Kiessling A, Zethraeus N, Henriksson P. Cost of lipid lowering in patients with coronary artery disease by Case Method Learning. Int J Technol Assess Health Care 2005, 21:180-186.
60. Kim J, Henderson RA, Pocock SJ, Clayton T, Sculpher MJ, Fox KAA. Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: One-year results of the third randomized intervention trial of unstable angina (RITA-3). J Am Coll Cardiol 2005, 45:221-228. 10.1016/j.jacc.2004.10.034, 15653019.
61. Kruse M, Hochstrasser S, Zwisler AD, Kjellberg J. Comprehensive cardiac rehabilitation: A cost assessment based on a randomized clinical trial. Int J Technol Assess Health Care 2006, 22:478-483. 10.1017/S0266462306051403, 16984681.
62. Lacey EA, Musgrave RJ, Freeman JV, Tod AM, Scott P. Psychological morbidity after myocardial infarction in an area of deprivation in the UK: evaluation of a self-help package. Eur J Cardiovasc Nurs 2004, 3:219-224. 10.1016/j.ejcnurse.2004.06.005, 15350231.
63. Legrand VMG, Serruys PW, Unger F, van Hout BA, Vrolix MCM, Fransen GMP, Nielsen TT, Paulsen PK, Gomes RS, de Queiroz de Melo J, Marques dos Santos Neves J, Lindeboom W, Backx B. Three-Year Outcome After Coronary Stenting Versus Bypass Surgery for the Treatment of Multivessel Disease. Circulation 2004, 109:1114-1120. 10.1161/01.CIR.0000118504.61212.4B, 14993134.
64. The Community Pharmacy Medicines Management Project Evaluation Team The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Fam Pract 2007, 24:189-200. 10.1093/fampra/cml075, 17272285, The Community Pharmacy Medicines Management Project Evaluation Team.
65. Puskas JD, Williams WH, Mahoney EM, Huber PR, Block PC, Duke PG, Staples JR, Glas KE, Marshall JJ, Leimbach ME, McCall SA, Petersen RJ, Bailey DE, Weintraub WS, Guyton RA. Off-Pump vs Conventional Coronary Artery Bypass Grafting: Early and 1-Year Graft Patency, Cost, and Quality-of-Life Outcomes: A Randomized Trial. JAMA 2004, 291:1841-1849. 10.1001/jama.291.15.1841, 15100202.
66. Reeves BC, Angelini GD, Bryan AJ, Taylor FC, Cripps T, Spyt TJ, Samani NJ, Roberts JA, Jacklin P, Seehra HK, Culliford LA, Keenan DJM, Rowlands DJ, Clarke B, Stanbridge R, Foale R. A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery. NCCHTA Health Technol Assess 2004, 8:1-56.
67. Sharples L, Hughes V, Crean A, Dyer M, Buxton M, Goldsmith K, Stone D. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. 11(49). NCCHTA Health Technol Assess 2007, 11:1-136.
68. Shrive FM, Manns BJ, Galbraith PD, Knudtson ML, Ghali WA, . for The APPROACH Investigators Economic evaluation of sirolimus-eluting stents. CMAJ 2005, 172:345-351. 545758, 15684117, for The APPROACH Investigators.
69. Taylor RS, Watt A, Dalal HM, Evans PH, Campbell JL, Read KLQ, Mourant AJ, Wingham J, Thompson DR, Pereira Gray DJ. Home-based cardiac rehabilitation versus hospital-based rehabilitation: A cost effectiveness analysis. Int J of Cardiol 2007, 119:196-201.
70. Xie J, Wu EQ, Zheng ZJ, Sullivan PW, Zhan L, Labarthe DR. Patient-Reported Health Status in Coronary Heart Disease in the United States: Age, Sex, Racial, and Ethnic Differences. Circulation 2008, 118:491-497. 10.1161/CIRCULATIONAHA.107.752006, 18625894.
71. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. N Engl J Med 2005, 352:1539-1549. 10.1056/NEJMoa050496, 15753115.
72. Holland R, Brooksby I, Lenaghan E, Ashton K, Hay L, Smith R, Shepstone L, Lipp A, Daly C, Howe A, Hall R, Harvey I. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BMJ 2000, 334:1098.
73. Sharples L, Buxton M, Caine N, Cafferty F, Demiris N, Dyer M, Freeman C. Evaluation of the ventricular assist device programme in the UK. NCCHTA Health Technol Assess 2006, 10:1-138.
74. Spencer CA, Norman PE, Jamrozik K, Tuohy R, Lawrence-Brown M. Is screening for abdominal aortic aneurysm bad for your health and well-being?. ANZ J Surg 2004, 74(12):1069-1075. 10.1111/j.1445-1433.2004.03270.x, 15574151.
75. Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context. NCCHTA Health Technol Assess 2006, 10:1-132.
76. Groeneveld P, Matta M, Suh J, Yang F, Shea J. Quality of Life Among Implantable Cardioverter-Defibrillator Recipients in the Primary Prevention Therapeutic Era. Pacing Clin Electrophysiol 2007, 30:463-471. 10.1111/j.1540-8159.2007.00694.x, 17437568.
77. van Eck JW, van Hemel NM, van den Bos A, Taks W, Grobbee DE, Moons KG. Predictors of improved quality of life 1 year after pacemaker implantation. Am Heart J 2008, 156:491-497. 10.1016/j.ahj.2008.04.029, 18760131.
78. Park J, White AR, James MA, Hemsley AG, Johnson P, Chambers J, Ernst E. Acupuncture for Subacute Stroke Rehabilitation: A Sham-Controlled, Subject- and Assessor-Blind, Randomized Trial. Arch Intern Med 2005, 165:2026-2031. 10.1001/archinte.165.17.2026, 16186474.
79. Ryan T, Enderby P, Rigby AS. A randomized controlled trial to evaluate intensity of community-based rehabilitation provision following stroke or hip fracture in old age. Clin Rehabil 2006, 20:123-131. 10.1191/0269215506cr933oa, 16541932.
80. Xie J, Wu EQ, Zheng ZJ, Croft JB, Greenlund KJ, Mensah GA, Labarthe DR. Impact of Stroke on Health-Related Qualityof Life in the Noninstitutionalized Population in the United States. Stroke 2006, 37:2567-2572. 10.1161/01.STR.0000240506.34616.10, 16946158.
81. Innocenti AD, Elmfeldt D, Hansson L, Breteler M, James O, Lithell H, Olofsson B, Skoog I, Tenkwalder P, Zanchetti A, Wiklund I. Cognitive Function and Health-Related Quality of Life in Elderly Patients with Hypertension - Baseline Data from the Study on COgnition and Prognosis in the Elderly (SCOPE). 2002, 11:157-165. Blood Press.
82. Krijnen P, van Jaarsveld BC, Hunink MGM, Habbema JDF. The effect of treatment on health-related quality of life in patients with hypertension and renal artery stenosis. J Hum Hypertens 2005, 19:467-470. 10.1038/sj.jhh.1001847, 15759023.
83. Lindgren P, Kahan T, Poulter N, Buxton M, Svarvar P, Dahloff B, Jonsson B. Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy. Eur J Health Econ 2007, 8:25-30. 10.1007/s10198-006-0002-9, 17165074.
84. Cook TA, Galland RB. Quality of life changes after angioplasty for claudication: medium-term results affected by comorbid conditions. Cardiovasc Surg 1997, 5:424-426. 10.1016/S0967-2109(97)00037-9, 9350800.
85. de Vries M, Ouwendijk R, Flobbe K, Nelemans PJ, Kessels AG, Schurink GH, Vliet JA, Heijstraten FMJ, Cuypers JWM, Duijm LEM, van Engelshoven JMA, Hunink MGM, de Haan MW. Peripheral Arterial Disease: Clinical and Cost Comparisons between Duplex US and Contrast-enhanced MR Angiography--A Multicenter Randomized Trial. Radiology 2006, 240:401-410. 10.1148/radiol.2402050223, 16864668.
86. Safley DM, House JA, Laster SB, Daniel WC, Spertus JA, Marso SP. Quantifying Improvement in Symptoms, Functioning, and Quality of Life After Peripheral Endovascular Revascularization. Circulation 2007, 115:569-575. 10.1161/CIRCULATIONAHA.106.643346, 17242281.
87. Slovacek L, Slovackova B, Chovanec V. The effect of femoral and popliteal percutaneous transluminal balloon angioplasty on patients' quality of life. Sao Paulo Med J 2007, 125:250-252.
88. Bosch JL, Graaf Y, Hunink MGM. Health-Related Quality of Life After Angioplasty and Stent Placement in Patients With Iliac Artery Occlusive Disease: Results of a Randomized Controlled Clinical Trial. Circulation 1999, 99:3155-3160.
89. Burstrom K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results using the EQ-5D. Qual Life Res 2001, 10:621-635. 10.1023/A:1013171831202, 11822795.
90. Hung HF, Kao PF, Lin YS, Chen FC, Tsai JC, Chan P. Changes of Serum b-Endorphin by Programmed Exercise Training Are Correlated with Improvement of Clinical Symptoms and Quality of Life in Female Mitral Valve Prolapse Syndrome. Cardiology 2007, 108:252-257. 10.1159/000096952, 17108680.
91. Maliwa MA, Heijden GJMG, Bots ML, van Hout BA, Casselman FP, van Swieten H, Vermeulen FEE. Quality of life and NYHA class 30 years after mechanical aortic valve replacement. Cardiovasc Surg 2003, 11:381-387. 10.1016/S0967-2109(03)00030-9, 12958549.
92. Spiraki C, Kaitelidou D, Papakonstantinou V, Prezerakos P, Maniadakis N. Health-related quality of life measurement in patients with coronary heart disease and heart failure to a cardiology department of a secondary urban hospital in Greece. Hellenic J Cardiol 2008, 49:241-247.
93. van Exel NJA, Scholte op Reimer WJM, Koopmanschap MA. Assessment of post-stroke quality of life in cost-effectiveness studies: The usefulness of the Barthel Index and the EuroQoL-5D. Qual Life Res 2004, 13:427-433. 10.1023/B:QURE.0000018496.02968.50, 15085915.
94. de Vries M, Ouwendijk R, Kessels AG, de Haan MW, Flobbe K, Hunink MGM, van Engelshoven JMA, Nelemans PJ. Comparison of generic and disease-specific questionnaires for the assessment of quality of life in patients with peripheral arterial disease. J Vasc Surg 2005, 41:261-268. 10.1016/j.jvs.2004.11.022, 15768008.
95. Busschbach JJV, McDonnell JM, Tangelder MJD, Eikelboom BCM, Buskens EM, Algra AM, Lawson JEM. EuroQol values for economic modelling quality of life after infrainguinal bypass grafting surgery: a rectification. J Vasc Surg 1999, 30:1162-1163.